- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study
- Study type descriptors: Retrospective
- Study aim: To explore the real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir administered to outpatients diagnosed with COVID-19 who were at high risk of developing severe disease, particularly in regards to risk of hospitalisation and death in comparison to age-matched control groups
- Number of participants enrolled: 8480
- Study enrolling from to
- Study includes follow-up for 35 days
Study Data
- Elderly
- Fragile population
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
External Links
Other information
Funders:
- National Public Health Organization of Greece
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to